Biotech Plays
Biotechs can be both lucrative and risky. Some key dates coming up:
Aug. 24
U.S. Food and Drug Administration's responds to Cell Therapeutics'(CTIC) priority review request for pixantrone as a treatment for non-Hodgkin's lymphoma.
Sept. 1
The Oncologic Drug Advisory Committee of the Food and Drug Administration meets to review Genzyme's(GENZ) Clolar and Vion Pharmaceuticals'(VION.OB Quote) Onrigin, both as a treatment for acute myeloid leukemia.
Sept. 2
The same FDA advisory committee meets to review Allos Therapeutics'(ALTH) pralatrexate for peripheral T-cell lymphoma.
FDA approval decision date for Endo Pharmaceuticals'(ENDP) Nebido, a long-acting testosterone replacement therapy.
Sept. 7
FDA approval decision date for Spectrum Pharmaceuticals'(SPPI) Zevalin, a drug for non-Hodgkin's lymphoma.
Sept. 9-10
Robert W. Baird Small Cap Health Care Conference
Sept. 9-11
Thomas Weisel Partners Healthcare Conference (Boston) and the Rodman & Renshaw 11th Annual Healthcare Conference (New York City)
Sept. 11-15
American Society for Bone and Mineral Research (ASBMR)
Sept. 12-15
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Sept. 13-15
American College of Clinical Pharmacology (ACCP)
Sept. 14-15
Morgan Stanley Healthcare Unplugged Conference
Sept. 16
The 16th Annual NewsMakers in the Biotech Industry, sponsored by BioCentury.
The Arthritis Drugs Advisory Committee of the FDA will review Auxilium Pharmaceutical's(AUXL) Xiaflex for advanced Dupuytren's disease, a condition in which the tendons of the hand that help move the fingers of the hand become thickened and scarred.
FDA approval decision date for Theravance's(THRX) antibiotic Telavancin.
Sept. 20-24
European Cancer Organization and European Society for Medical Oncology Multidisciplinary Congress
Sept. 21-23
UBS Global Life Science Conference
Sept. 24
FDA approval decision date for Eurand Pharmaceuticals'(EURX) Zenpep, a drug for pancreatic insufficiency.
FDA approval decision date for Allos Therapeutics' Pralatrexate for peripheral T-cell lymphoma.
Dendreon(DNDN Quote) analyst day
Sept. 27-Oct. 1
European Association for the Study of Diabetes (EASD)
Important clinical trials with potential data readouts in September:
Company: Osiris Therapeutics(OSIR)
Drug/indication: Prochymal for graft-vs.-host disease
Company: Acadia Pharmaceuticals(ACAD)
Drug/indication: pimavanserin for Parkinson's disease pychosis (PDP)
Company: Arena Pharmaceuticals(ARNA)
Drug/indication: lorcaserin for obesity
Company: Chelsea Therapeutics(CHTP)
Drug/indication: droxidopa for orthostatic hypotension
__________________
You can also read articles that I've written, video charts that I do and keep up with market news at www.otcshowcase.com.
"Always bear in mind that your own resolution to success is more important than any other one thing." - Abraham Lincoln
"The heights by great men reached and kept, were not obtained by sudden flight. But they, while their companions slept, were toiling upward in the night." - Longfellow
Full Disclosure
Last edited by Klipper22; 08-18-2009 at 11:08 AM.
|
Linear Mode
